
Professor William Abraham
The Ohio State University, Columbus (United States of America)
Membership:
FESC Member
HFA Member
Follow
Biography
Dr. Abraham earned his MD from Harvard Medical School and completed post-graduate training in Internal Medicine, Cardiovascular Medicine, and Advanced Heart Failure/Transplant Cardiology at the University of Colorado. At Ohio State University, Dr. Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 20 consecutive years. His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair. He has authored more than 1,500 original works and been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds. He received the 2017 Distinguished Scientist Award from the American College of Cardiology.
Contributor content
Session
Unlocking the potential of baroreflex activation in heart failure patients
21 May 2023
Session
Cardiac resynchronization therapy
20 May 2023
Session
Acute heart failure - Biomarkers
29 August 2022
Session
Diagnostic and prognostic value of biomarkers in acute heart failure
22 May 2022
Session
Big Brother is watching you: role of telemonitoring in the management of advanced heart failure.
21 May 2022
Session
Rapid parade of devices: emerging treatment options in heart failure, Part 2
1 July 2021
Session
Expert opinion on heart failure management: devices
1 July 2021
Session
Treating common comorbidities (iron deficiency and sleep apnoea)
30 June 2021
Session
Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
28 August 2018
Session
Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?
26 May 2018

